Victor Bornsztejn

Victor Bornsztejn is a seasoned executive with extensive experience in the biotechnology and life sciences industries. In January 2025, he was appointed as the Senior Vice President of Commercial at Culture Biosciences. In this strategic role, Victor oversees the company's commercial direction and leads the launch of its innovative new product, Stratyx™ 250.

Throughout his career, Victor has held senior positions at prominent companies such as Thermo Fisher, Sartorius, and GE Healthcare (now Cytiva). He has successfully scaled commercial operations, driven market expansion, and overseen the launch of cutting-edge products that transform the way scientists and companies approach complex challenges.